Faiez Zannad speaks to Javed Butler about the FDA approval of new drug, vericiguat, for heart failure with reduced ejection fraction, following the publication of the VICTORIA trial in 2020.

Alexandra Nowbar

+ posts

• Alexandra Nowbar

  https://cvctcardiobrief.com/author/alex-nowbar/

  A Pragmatic Trial isn’t just a Simple Trial: An Interview with Colin Baigent about ADAPTABLE
• Alexandra Nowbar

  https://cvctcardiobrief.com/author/alex-nowbar/

  Speculations on PARADISE-MI (sacubitril/valsartan post-MI) before the full results
• Alexandra Nowbar

  https://cvctcardiobrief.com/author/alex-nowbar/

  Wishful Thinking About Revascularization for Stable Coronary Artery Disease
• Alexandra Nowbar

  https://cvctcardiobrief.com/author/alex-nowbar/

  Meet Spironolactone and Eplerenone’s Cardio-kidney Cousin, Finerenone